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Abstract: The increase of multidrug-resistant bacteria remains a global concern. Among the proposed
strategies, the use of nanoparticles (NPs) alone or associated with orthopedic implants represents a
promising solution. NPs are well-known for their antimicrobial effects, induced by their size, shape,
charge, concentration and reactive oxygen species (ROS) generation. However, this non-specific
cytotoxic potential is a powerful weapon effective against almost all microorganisms, but also against
eukaryotic cells, raising concerns related to their safe use. Among the analyzed transition metals,
silver is the most investigated element due to its antimicrobial properties per se or as NPs; however,
its toxicity raises questions about its biosafety. Even though it has milder antimicrobial and cytotoxic
activity, TiO2 needs to be exposed to UV light to be activated, thus limiting its use conjugated to
orthopedic devices. By contrast, gold has a good balance between antimicrobial activity as an NP
and cytocompatibility because of its inability to generate ROS. Nevertheless, although the toxicity
and persistence of NPs within filter organs are not well verified, nowadays, several basic research
on NP development and potential uses as antimicrobial weapons is reported, overemphasizing NPs
potentialities, but without any existing potential of translation in clinics. This analysis cautions
readers with respect to regulation in advancing the development and use of NPs. Hopefully, future
works in vivo and clinical trials will support and regulate the use of nano-coatings to guarantee safer
use of this promising approach against antibiotic-resistant microorganisms.
Keywords: nanoparticles; orthopedic infections; transition metals; antibacterial coatings; biofilm;
antibiotic-resistant microorganisms
1. Introduction
Multidrug-resistant (MDR) bacteria remain a global concern, resulting in infectious diseases
that are more and more difficult to treat [1]. The development of antibiotic resistance is related to
Materials 2019, 12, 314; doi:10.3390/ma12020314 www.mdpi.com/journal/materials
Materials 2019, 12, 314 2 of 20
several key factors correlated with the misuse of antibiotics: (1) the overuse of antibiotics; (2) the
inappropriate or suboptimal prescription of these drugs reported in 30–50% of cases [1]; (3) the lack
of information and education, which lead patients to prematurely interrupt the antibiotic course;
the purchase of antibiotics without a medical prescription [2]; and (4) the decline of investments in
new drug development in the pharmaceutical industry due to marketing concerns [3].
In orthopedics, the implantation of devices (e.g., prosthesis, plate, and screws, etc.) establishes a
non-negligible incidence of infections, representing one of the major causes of morbidity and mortality
in this medical field [4,5]. Despite prophylaxis, it has been estimated that 0.4–2% of patients develop
this harmful complication following primary implantation and 5–15% after revision surgery [6–8].
The presence of a foreign body is the triggering event for implant-associated infections, because the
surface and roughness of these biomaterials not only attract the host eukaryotic cells involved in the
regeneration of tissues, but also free-floating bacteria. Indeed, as soon as a contamination occurs,
the “race to the surface” begins, as first described by Gristina and colleagues, determining the fate of the
development of the infection [9]. If the race to the surface is won by cells of the surrounding tissue, the
implant surface will be occupied and, therefore, defended. Otherwise, bacteria rapidly adhere to the
biomaterial and colonize the surface due to several physicochemical interactions (e.g., van der Waals
and gravitational forces, electrostatic repulsion, and ionic and dipole interactions). Thereafter, bacteria
start to proliferate and to aggregate in clusters through cell-to-cell adhesion. Guided by molecular
signals, they secrete an extracellular polymeric matrix to form a multi-layered biofilm [10,11]. Biofilms
enable bacteria to live in a protected environment with a renewable nutrient supply, without being
affected by the physical forces associated with the fluid stream or by the host immune system [12].
Under such conditions, the minimum inhibitory concentration (MIC) of antimicrobial substances
is 10–103 times higher, thus enhancing the development of resistance in bacterial communities [13].
Hence, minimizing the risk of implant-related infections, emphasizing prophylaxis measures while
discouraging the impairment of bone healing become of critical importance.
To face the problem, different strategies have been proposed and pursued, such as the modification
of the existing antimicrobial substances or the development of more effective ones to overcome bacterial
resistance [14]. Among new perspectives proposed to combat and defeat both implant-associated
infections and the rise of antimicrobial resistance, the use of nanoparticles (NPs) alone or associated
with orthopedic implants as coatings represents a possible and promising solution. In particular,
nano-sized transition metals (e.g., silver, gold, copper, zinc oxide, titanium dioxide, etc.,) demonstrate
a versatile and controllable application in the fight against infections and antibiotic resistance
development. Indeed, this strategy exploits the ability of NPs to cause bacterial damages at the
molecular level, due to their ultra-small dimensions increasing the biophysical interaction with
bacteria and the generation of free radicals [15]. Furthermore, metallic NPs play a crucial role in the
prevention of biofilm formation, including Ag NPs, Au NPs, ZnO NPs, CuO NPs, Fe3O4 NPs [16–18].
As aforementioned, a smaller size and higher surface area-to-mass ratio are the performance-enhancing
factors, but the shape of metal NPs also has a remarkable effect against biofilms [19].
Many concerns have been expressed by the scientific community whether the extremely active
NPs might be a threat for bone cells surrounding the implanted devices and for tissues and organs.
Indeed, a negative influence of NPs on eukaryotic cells like osteoblasts, osteoclasts, and bone marrow
mesenchymal stem cells might result in an impairment in the implant integration in the absence of a
bacterial infection. Fortunately, nowadays, nanotechnology offers novel materials able to support the
host tissue function, favoring osteoblast attachment, proliferation, and synthesis of the extracellular
matrix and enabling the osseointegration of the implant [20].
In this context, nanomaterials can be considered strong candidates in the control of resistant
bacterial infections, limiting the consumption of antibiotics. Hence, the aim of this review is to describe
different inorganic transition metal-based NPs and their antimicrobial and possible cytotoxic activity
alone or conjugated with implantable materials to elucidate their promising role in orthopedics.
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2. Antibacterial Properties of NPs: Mechanisms of Action
Metal and metal oxide NPs are well-known for their antimicrobial effects and, their extensive use
in several clinical and industrial setting dates back to several decades ago [5].
Although not all the transition metal NPs share the same mechanisms of action, the properties of
the majority of NPs are related to both their physical structure and to their specific interaction with
biofilm producers. Several factors might induce and promote antimicrobial activity, like the (1) size
and (2) shape of NPs. Indeed, as the NP size decreases, not only does their stability increase, but also
the surface/volume ratio, conferring them a higher ability to interact with the cell membrane and
consequently to have higher antimicrobial potential [21,22]. This interaction is also possible due to
the key role played by the (3) electrostatic forces guiding bacterial and NP attraction. Indeed, most
bacteria have a negatively charged cell wall that attracts positively charged molecules [23]. Positively
charged ions or NPs can easily enter microorganisms, damaging their inner structures by binding
negatively charged proteins and nucleic acids [24]. Furthermore, similar to any other antimicrobial
agent, the bactericidal effect of NPs depends on the concentration (4), which can vary based on different
bacterial susceptibility depending on the different microorganism classes. All the listed variables
cooperate to confer NPs an antimicrobial effect amplified by the release of ions (5) [25]. Nevertheless,
the (6) generation of reactive oxygen species (ROS) plays a crucial role in the bactericidal effect of
NPs. Indeed, the local production of oxygen-free radicals leads to peroxidation of lipids, alteration
at proteomic and enzymatic levels and also damages RNA and DNA (Figure 1) [5]. This cytotoxic
and genotoxic potential is a powerful, non-specific weapon effective against almost all the type of
microorganisms and also eukaryotic cells, raising many concerns related to the biocompatibility of NPs.
Indeed, even if mammalian cells are able to limit the free-radical damage when ROS production exceeds
this capability, it results in oxidative stress, inflammation, and irreparable damage to membranes,
proteins, and DNA. Hence, to avoid any dangerous effects on eukaryotic cells, it is important to
respect the concentration window that regulates the use of NPs in order to kill microorganisms without
detrimental effects on osteoblasts and other host cells [26].
Materials 2018, 11, x FOR PEER REVIEW    3  of  19 
 
Metal and metal oxide NPs are well‐known for their antimicrobial effects and, their extensive 
use in several clinical and industrial setting dates back to several decades ago [5].   
Although not all the transition metal NPs share the same mechanisms of action, the properties 
of the majority of NPs are related to both their physical structure and to their specific interaction with 
biofilm producers. Several factors might induce and promote antimicrobial activity, like the (1) size 
and (2) shape of NPs. Indeed, as the NP size decreases, not only does their stability increase, but also 
the surface/volume ratio, conferring  them a higher ability  to  interact with  the cell membrane and 
consequently to have  igher antimicrobial potential [21,22]. This interaction is also possible due to 
th  key role played by the (3) electrostatic forces guiding bacterial and NP attraction. Indeed, most 
bacteria have a negatively charged cell wall that attracts positively charged molecules [23]. Positively 
charg d ions or NPs can easily enter microorganisms, damaging their inner structur s by binding 
negatively charged proteins and nucl ic acids [24]. Furtherm re, similar to  y other antimicrobial 
agent,  the bactericidal  effect of NPs depends on  the  concentration  (4), which  can vary based on 
different bacterial  susceptibility depending on  the different microorganism  classes. All  the  listed 
variables cooperate  to confer NPs an antimicrobial effect amplified by  the release of  ions  (5)  [25]. 
Nevertheless,  the  (6)  generation  of  reactive  oxygen  species  (ROS)  plays  a  crucial  role  in  the 
bactericidal effect of NPs. Indeed, the local production of oxygen‐free radicals leads to peroxidation 
of lipids, alteration at proteomic and enzymatic levels and also damages RNA and DNA (Figure 1) 
[5]. This cytotoxic and genotoxic potential is a powerful, non‐specific weapon effective against almost 
all  the  type  of microorganisms  and  also  eukaryotic  cells,  raising many  concerns  related  to  the 
biocompatibility of NPs. Indeed, even if mammalian cells are able to limit the free‐radical damage 
when  ROS  production  exceeds  this  capability,  it  results  in  oxidative  stress,  inflammation,  and 
irreparable damage  to membranes, proteins, and DNA. Hence,  to avoid any dangerous effects on 
eukaryotic cells, it is important to respect the concentration window that regulates the use of NPs in 
order to kill microorganisms without detrimental effects on osteoblasts and other host cells [26]. 
 
Figure  1.  Schematic  representation  of  the  reaction  of  bacteria  following  the  exposure  to  reactive 
oxygen species generated by NPs and ions. The illustration shows (A) cell wall disruption and NP 
and ion penetration, (B) the interruption of electron transport, (C) damages to the ribosome affecting 
the protein synthesis, (D)  intercalation between DNA bases with consequent  irreparable damages, 
and (E) the negative interaction with plasmid DNA. 
3. Transition Metal NPs with Antimicrobial Activity for Potential Use in Orthopedics 
Figure 1. Schematic representation of the reaction of bacteria following the exposure to reactive oxygen
species generated by NPs and ions. The illustration shows (A) cell wall disruption and NP and ion
penetration, (B) the interruption of electron transport, (C) damages to the ribosome affecting the protein
synthesis, (D) intercalation between DNA bases with consequent irreparable damages, and (E) the
negative interaction with plasmid DNA.
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3. Transition Metal NPs with Antimicrobial Activity for Potential Use in Orthopedics
3.1. Silver
Silver (Ag) has long been recognized for its antibacterial properties. Ag antiseptic and
antimicrobial features against Gram-positive, Gram-negative bacteria and fungi, indeed, date back to
several decades ago [27,28]. Nowadays, Ag is frequently used in many different forms and is applied
in several medical fields, among them in wound or burns as dressings, creams, or spray and as a
coating on implantable devices. Due to the lack of mechanical strength, Ag is not currently employed
as a bulk material for the production of orthopedic implants. However, Ag is often employed in
the modification of the surface of some specific implants called “megaendoprosthesis”, used in the
treatment of bone tumors or in the case of revision surgeries of septic devices [29]. Indeed, the ions
released from the Ag-coated prosthesis demonstrated a high and broad-spectrum antibacterial effect,
necessary for the prevention of infections associated with implantable devices in subjects with a higher
risk factor, such as immunocompromised, oncologic or elderly patients.
Silver nanoparticles (Ag NPs), either metallic Ag0 or ion form Ag+, are now preferred to improve
the effects of Ag [25,30] and, nowadays, this nanotechnology has several biomedical applications [31].
In this context, Ag NPs might be deposed on the surface of implantable materials as a thin film with
controlled density, thickness, and stability over time, in order to prevent biofilm formation on these
devices [32–37].
Differently from antibiotics, the effects of Ag NPs are not limited to a single mechanism, but more
than one event can occur simultaneously. When the Ag NPs come into conflict with prokaryotic cells,
the affinity of Ag ions for sulfhydryl and thiol groups blocks the cellular respiratory chain, affecting
also the cell transport system interfering with the cellular permeability [38]. Nonetheless, the positive
electric charge of Ag NPs is crucial for NP interaction with the negatively charged bacterial wall and
for the consequent ion penetration and ROS generation, leading to DNA and RNA damages, affecting
protein synthesis and other vital processes [13,27]. Many in vitro and in vivo studies evaluated the
activity of Ag NPs against microorganisms and, based on those results it could be speculated that
the cytotoxic effect of Ag NPs is size-, concentration- and exposure time-dependent [39]. Indeed, as
the Ag NP size decreases, not only does their stability increases, but also the surface/volume ratio,
conferring them a higher ability to penetrate the cell membrane and consequently to have a higher
antimicrobial potential [21,22]. Moreover, it has been demonstrated that Ag NPs interact with bacteria
and fungi in a shape-dependent manner [28,40]. In recent research, Raza and colleagues verified
whether the antimicrobial activity might be affected by Ag NP size and shape, concluding that the
smallest spherical Ag NPs (15 to 50 nm) had a higher effect on Pseudomonas aeruginosa and Escherichia
coli viability than triangular and larger spherical Ag NPs (150 nm and 30–80 nm, respectively) [40].
The different morphology might have a crucial role in the antimicrobial properties of Ag NPs, since
depending on the shape, NPs might have different exposed surface areas in terms of active facets [41].
Nevertheless, the bactericidal effect of Ag depends on the NP concentration, which varies based
on different bacterial susceptibility depending on the different microorganisms class. For instance,
S. aureus requires a concentration of 33 nM to be inhibited, while E. coli is inhibited at lower
concentrations (3.3 nM) [42]. All the listed variables cooperate to confer Ag NPs the antimicrobial
effect that can be amplified by the combination of antibiotics (i.e., ciprofloxacin, imipenem, gentamycin,
vancomycin, and trimethoprim), creating a synergic effect [43]
The antimicrobial properties of Ag are recognized and well documented, and it has been described
how Gram-negative bacteria are able to acquire resistances, inducing phenotypic changes to efflux
transporter leading to the reduction of intracellular levels of Ag [44]. Indeed, this mechanism might
involve the reduction of Ag+ to a less toxic neutral oxidation or it might be determined by the active
efflux of Ag+ from the cell by either P-type adenosine triphosphatases or chemiosmotic Ag+/H+
antiporters [45]. Furthermore, it has been recently demonstrated how the exposure of Gram-negative
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bacteria (i.e., E. coli and P. aeruginosa) to subinhibitory concentrations of Ag NPs is able to induce
production of flagellin that aggregates Ag NPs, reducing their antibacterial effect [46].
Finally, many concerns have been expressed by the scientific community whether Ag NPs might
be a threat for eukaryotic cells surrounding the implanted devices and for tissues and organs [47].
Indeed, Ag NPs are known to be toxic to eukaryotic cells present in the bone, such as osteoblasts
and osteoclasts depending on their concentration. Hence, different studies have been conducted to
assess the cyto- and genotoxic potential effects of Ag NPs on human osteoblast-like cells or human
mesenchymal stem cells in vitro and in vivo [48–50]. These analyses indicated a toxic effect strictly
related to the concentration of Ag NPs that sometimes is able to trigger the generation of ROS and
the subsequent oxidative damage to cellular components. However, human osteoblast-like cells
demonstrated the ability to adapt in order to survive the presence of a moderate quantity (5 µg/mL)
of Ag NPs [49].
Hence, the beneficial advantage in the use of Ag NPs lies in a wide therapeutic window; it has been
demonstrated that very small concentrations of Ag NPs (35 ppb) are sufficient to induce bactericidal
effects, while concentrations of 300–1200 ppb are cytotoxic to mammalian cells [27,51]. As a matter of
fact, several severe side effects (e.g., argyria, leukopenia, damages of kidney, liver and neural tissue,
etc.) were documented in the presence of 300 ppb of Ag NPs in the bloodstream. Conversely, blood
concentrations of 56 ppb of Ag NPs can be considered biocompatible [29].
3.2. Gold
The lower toxicity compared to other inorganic NPs, ease synthesis and functionalization make
gold NPs (Au NPs) optimal candidates to forestall the growth and adhesion of microorganisms [15].
Different from Ag, Au is an inert material, which lacks antibacterial properties, unless manufactured
into nanostructures with rough surfaces [14]. Moreover, the antimicrobial activities of Au NPs are quite
different from any other NPs because they are not induced by the generation of ROS, hypothesizing a
safer use of these NPs in clinical settings [52].
Therefore, the MIC is significantly higher in Au NPs compared to Ag NPs to achieve antimicrobial
activity. However, it has been demonstrated that a concentration of at least 120 µg/mL can have an
impact on microorganisms, damaging the cell wall and interfering with cell function [53]. In particular,
Au NPs have a confirmed antifungal activity depending on the effect of size and shape of particles,
which modulate the amount of exposed active surface [53]. Indeed, the shape of Au NPs can be
controlled during the synthesis process, and a wide variety of morphologies can be molded, such as
rods, plates, branched structures, etc. [54]. Depending on the size and mostly on the shape of NPs,
the surface area ratio changes accordingly. This effect was described in a study on various species of
Candida, in which Au NPs shaped as discs (25 nm) displayed higher fungicidal activity compared to
the Au NPs with a polyhedral structure (30 nm), with an MIC of 16–32 µg/mL and 32–128 µg/mL,
respectively [55].
Nonetheless, Au can be functionalized to amplify the antimicrobial effect against most
Gram-positive and negative bacteria. Indeed, Au NPs and nano-rods can acquire a higher
bactericidal effect when conjugated and photothermally activated, for example, against P. aeruginosa,
as demonstrated by Norman et al. [56]. In another recent study proposed by Li and colleagues [14],
cationic and hydrophobic functionalized Au NPs played an active role in the inhibition of 11 of clinical
MDR isolates, proposing a valid solution to impede the antibiotic resistance. The antimicrobial
action explained in the study underlined that cationic and hydrophobic Au NPs promoted the
interaction with the cell membrane of Gram-positive and negative bacteria, resulting in the lysis
of their membranes. To enhance their antimicrobial activity, Au NPs can be also conjugated with
various molecules or employed as local carriers, strengthening the antimicrobial effects due to a
synergistic mechanism of action [57,58]. This specific feature not only can be exploited to carry
antimicrobial molecules, but also genes or drugs taking advantage of Au NPs internalization within
eukaryotic cells throughout nonspecific endocytosis. However, it has been demonstrated that once
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Au NPs are internalized by osteoblasts, they cannot be degraded, whereas they can be enclosed in
lysosome vesicles in the cytoplasm. Although the cell viability, proliferation, and differentiation are not
compromised, the Au NP internalization might interfere with proteins and consequently with the cell
metabolism [59,60]. Once again, the size of Au NPs plays an important role in enhancing some cellular
functions. In particular, Au NP rods (70 nm in size) markedly promoted the osteogenic differentiation
of mesenchymal stem cells, while 40 nm rod-shaped Au NPs suppressed the osteogenic differentiation
process [61].
Despite that a higher concentration of Au NPs is required to achieve the antimicrobial potential
compared to Ag NPs, the use of Au NPs in orthopedics should not be excluded. Indeed, the conjugation
of these NPs to implantable materials might be an encouraging strategy to counteract infections while
promoting a safer use, as reported by Yang and colleagues, who described the Au NP-modified surface
of titanium dioxide nanotubes as promising candidates for orthopedics [62].
3.3. Copper
Copper (Cu) is a necessary trace element in the human body, and, like many other transition
metals, it also possesses some antimicrobial properties [63]. The metal oxide form of Cu (CuO) has been
proposed because of its bactericidal effect against different microorganisms. It has been demonstrated
that CuO also plays a fundamental role in the alteration of the expression and catalytic activities of
some enzymes due to the reaction with protein sulfhydryls, causing damage to key proteins [64,65].
Moreover, similar to Ag NPs and Au NPs, CuO NPs are able to interact with the bacterial cell wall,
causing severe damage. Indeed, the oxidative stress enhanced by the CuO NP production of ROS
contributes to change the bacterial membrane permeability followed by microorganism death [19].
Furthermore, Cu ions (Cu2+) work as a donor/acceptor of electrons by switching between the redox
states of Cu+ and Cu2+, which causes bacterial damages [66]. Similar to other transition metals,
the shape, size, and microstructures are the principal factors influencing the antibacterial properties of
Cu NPs [67]. It has been described that Cu NPs have a greater inhibition effect against E. coli compared
to the Gram-positive S. aureus [67]. This antibacterial effect is mainly due to the interaction of Cu
NPs and the bacterial cell wall which is extremely negatively charged in Gram-negative bacteria.
Furthermore, the physical characteristics of CuO NPs significantly affect their antibacterial potential.
Indeed, it has been demonstrated that thin CuO nanorods (Φ 5–15 nm; length 50–100 nm) have higher
antibacterial effects compared to thicker CuO rods (Φ 10–40 nm; length 50–400 nm) because of their
greater ability to penetrate the cell wall membrane [68].
Different from Ag NPs, CuO NPs have reduced antibacterial power, requiring higher
concentrations (100–5000 µg/mL) to achieve the inhibition of microorganisms, thus raising concerns
in the biosafety of CuO [69]. This intrinsic limitation can be easily bypassed by using CuO in
association with other materials. For instance, CuO in combination with zinc oxide NPs demonstrated
a significant inhibitory effect on oral biofilm models [70]. Moreover, the combination of NPs and
titanium dioxide coatings resulted in a synergistic effect supporting the apatite formation process,
biocompatibility, osteoconductivity, and antimicrobial activity [71]. This synergistic effect was also
reported by Shi et al. [72] in association with hydroxyapatite that promoted bone regeneration,
modulating the balance between osteoblasts and osteoclasts, together with an antimicrobial activity
against S. aureus and E. coli with excellent biocompatibility.
As a bulk material, Cu is not used for orthopedic applications. However, CuO NPs associated
with materials commonly employed in prosthetic surgery or bone grafting might enhance the implant
integration while preventing infections.
3.4. Titanium
Titanium dioxide (TiO2) is frequently employed as biomaterial coating due to its antibacterial
properties, non-toxicity, stability and relatively low manufacturing costs [73]. The interest in this metal
arises from the intensive use of pure titanium (Ti) and titanium alloys, as most of the implantable
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orthopedic devices are made of these materials for their mechanical strength and resistance to fatigue,
as well as bone affinity and osteoconductivity. A TiO2 thin film can be used to cover Ti or other alloys to
preserve the features of the bulk materials and to protect their surface from threats driven by biological
fluids, such as bacteria, through its crystal structure [74,75]. It has been previously reported that the
exposure of material to ultraviolet (UV) light activates metal oxide, and that UV-activated TiO2 can
damage a wide range of microorganisms such as Gram-positive and negative bacteria, fungi, algae,
protozoa and viruses [76,77]. However, the activation process can be considered as a limitation in
the use of TiO2; indeed, to enable the catalytic process, photons have to reach the material surface.
Furthermore, the TiO2 exposure to long-wave UV (UVA) light activates metal oxide, leading to the
formation of ROS, such as superoxide anion radicals and free hydroxyl, hydrogen peroxide, and singlet
oxygen in aqueous solutions [78]. The limitation of TiO2 photo-activation together with the cytotoxicity
towards multiple bone-related cells discourages the use of this NP in the orthopedic field. Also, the
association of TiO2 NPs with orthopedic devices may lead to osteolysis, implant aseptic loosening and
non-specific pain related to the alteration of bone homeostasis causing bone resorption [79].
3.5. Zinc
Zinc oxide (ZnO) NPs have multiple biological applications, as they are already used in the
cosmetic and the sunscreen market for their physical properties, i.e., transparency and ability to reflect,
scatter, and absorb UV radiation [80]. Furthermore, similar to other NPs, ZnO has a broad spectrum of
antibacterial activity due to its physical properties. Indeed, the surface-to-volume ratio confers ZnO
NPs the ability to interact with negatively charged bacteria, inhibiting their growth and adhesion [81].
The toxicity of ZnO NPs is also attributed to the release of Zn ions, which significantly influence the
active transport of prokaryotic cells and the synthesis of proteins and ZnO accumulation in the cell
cytoplasm [82]. Furthermore, the release of Zn ions also promotes the formation of hydrogen peroxide
and ROS, another effective weapon against bacteria. However, the presence of low concentrations
Zn2+ in the surrounding areas might induce the tolerance of bacteria to this material [81]. The bacterial
resistance mechanisms to metal ions can occur at the extracellular or intracellular level by sequestering
metal particles, reducing the permeability, or directly expelling the metal ions [83].
Among pathogens affected by ZnO activity, S. aureus and S. epidermidis, S. pyogenes, B. subtilis, and
E. faecalis have been documented [84]. In addition, Campylobacter jejuni and other foodborne pathogens
are affected by these NPs, demonstrating a downregulation of the virulence genes, such as cell motility,
toxin production, and adhesion to host cells after treatment [85]. The concentration, shape, and size of
ZnO have a determinant role in the antimicrobial activity of NPs. A recent study described how the
modulation of the shape and size of ZnO enhanced the activity against bacteria [68]. In particular, the
authors showed that ZnO cone NPs (Φ 80–100 nm; length 100–160 nm; 8.7 m2/g) had a higher activity
compared to both ZnO with hexagonal shape (60–100 nm; 8.6 m2/g) and ZnO nanorods (Φ 30–40 nm;
length 140–320 nm; 2.7 m2/g) because of their greater porosity and surface area [68].
More importantly, recent studies demonstrated how ZnO NPs have a selective toxicity to bacteria
with minimal effects on human cells, the latter being more resistant to NP effects [86]. Indeed,
Memarzadeh and colleagues recently described how ZnO NPs, as a coating material, inhibited S.
aureus adhesion while promoting osteoblast growth and the consecutive osseointegration of the
implant [87]. Even though a high cytocompatibility was described in the literature, it has been reported
that the shape of ZnO NPs not only influences the antimicrobial efficacy but also has adverse effects
against bone cells. Indeed, it has been demonstrated how spherical ZnO NPs are readily internalized by
osteoblasts without impeding any cell function and how ZnO rod-shaped NPs impaired cell viability
due to their physical properties [88].
Even if there is still a need to investigate all the possible side effects on other host cells (e.g.,
erythrocytes), the use of ZnO NPs might prevent the failure of implanted devices due to infections,
but also due to aseptic loosening improving their osseointegration through enhanced bone density
and mechanical properties [89].
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3.6. Zirconium
Zirconium (Zr) is a sturdy transition metal that received special interest in different biomedical
fields due to its physical features that resemble those of titanium [90]; nevertheless, bulk Zr is
not currently used to produce orthopedic implants. However, Zr alloys and zirconium dioxide
(ZrO2), commonly known as zirconia, are widely employed in orthopedics for joint replacement [91],
but also in dentistry for dental crown reconstruction and dental implants [92,93] due to its good
biocompatibility and high fracture strength [94]. Different from other oxides, there is currently a
lot of debate about whether ZrO2 NPs have a toxic activity against bacteria and fungi. Jangra and
colleagues [95] investigated the correlation between the morphology and physical properties of ZrO2
NPs and Zr complexes and antimicrobial activity against E. coli, S. aureus, Botrytis cinerea, Aspergillus
niger, and three other Aspergillus species. In this study, it was demonstrated how the structure of
ZrO2 NPs and Zr complexes (e.g., surface areas and specific crystal plane) might influence the activity
against bacteria. Indeed, it was observed that the ZrO2 nanostructures had an antibacterial activity
against E. coli, but not against S. aureus and fungi. Conversely, Zr complexes had an action against both
S. aureus and E. coli [95]. These results were ascribed to the atomic arrangements of different exposed
surfaces, and the authors concluded that ZrO2 NPs with the same surface areas but with different
shapes showed different antimicrobial activity [95].
Antimicrobial activity observed against Gram-negative bacteria was also reported by others
describing the inhibitory action of ZrO2 NPs against P. aeruginosa [96]. This phenomenon is probably
due to the outer membrane of Gram-negative bacteria that is mainly composed of phospholipids and
lipopolysaccharides, which are known to be strongly negatively charged. The bacteria’s negatively
charged cell surfaces attracted NPs, enhancing the toxic their activity [96]. The modest effects of ZrO2
NPs have been described by Banerjee and colleagues, who underlined again the importance of NP
structure and concentration that confer antimicrobial activity [97].
Even though studies on the antimicrobial properties of ZrO2 often report inconsistent results,
the zirconia-nanosized modification of metal implant surfaces might support a better integration
with the biological system for long-term applications. Indeed, the bioceramic nature of this material
enhances the expression of integrins and the hydrophilicity of implant surfaces, promoting the adhesion
of osteoblasts and subsequent bone maturation. Furthermore, a recent in vivo study demonstrated
the absence of delamination and wear debris of metal implants with a nanostructured zirconia
surface, along with the lack of any inflammatory and foreign body reaction [98]. These advantages
make zirconia a possible candidate as an antimicrobial material for orthopedic implants with low
adverse effects.
3.7. Iron
Iron (Fe) is fundamental for human and animal health. Indeed, this element has an important role
in oxygen transport and cellular respiration. The physiological Fe level is around 2.5–4 g in females and
males, respectively, distributed in hemoglobin throughout the body [99]. Furthermore, the uptake of
iron through the diet has been demonstrated to have a beneficial activity on bone mineral density [100].
Iron oxide NPs are currently employed in an expanding number of medical applications, from
cell labeling, separation and tracking to cancer therapy [101]. Nonetheless, superparamagnetic iron
oxide (SPIO) nanoparticles were proposed in clinics as long-term tracking/labeling system detectable
with imaging techniques already applied for diagnostic purposes [102] or proposed to evaluate the
outcome of tissue engineering strategies with magnetic resonance [103].
Iron in its bulk form is an inert material lacking antimicrobial properties [5]. Though, similar to
Au, when nano-synthesized, Fe acquires antimicrobial features.
A recent study investigated the properties of FeNPs against some Gram-negative (Erwinia
amylovora, Xanthomonas oryzae) and positive bacteria (Bacillus cereus and Streptomyces spp.) [104].
B. cereus and Streptomyces spp. demonstrated a higher tolerance, displaying only growth inhibition
without any bactericidal effect probably due to the thickness of the peptidoglycan membrane. It has
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been hypothesized that the bactericidal effect is once again mediated by the formation of ROS.
In particular, superoxide, hydroxyl radicals and hydrogen peroxide might lead to cytotoxic effects
not only in prokaryotic cells, but also the DNA and protein synthesis of eukaryotic cells [105].
Another recent study demonstrated the effects of Fe3O4 against Gram-negative bacteria (E. coli, Serratia
marcescens, and P. aeruginosa) and positive bacteria (S. aureus) [106]. The smaller the NPs size, the
larger the surface area interacting with bacteria and causing bacterial permeability leading to cellular
disruption. Indeed, Fe3O4 NPs are of particular interest as antibacterial agents because during the
synthesis process they can be molded with unusual crystalline morphologies with a high number of
edges and corners characterized by extremely high surface areas increasing their reactivity against
bacteria [107].
Furthermore, once again, it has been reported that the reduced iron species (Fe3+ and Fe2+) cause
the formation of ROS altering the intracellular balance by depolymerizing polysaccharides, breaking
DNA and inactivating enzymes, resulting in cell death [106]. Due to the increased use of FeNPs, many
efforts are currently made to assess the nanotoxicology and the potential damages on host cells derived
by the use of this metal [108,109]. Indeed, the conjugation of Fe3O4 to other materials reduces the
exposed NPs, and consequently decreases the formation of ROS from the Fe3O4 surface in contact with
body fluids and cells [110]. This successful strategy allowed the mineralization of the Fe3O4 NP-coated
materials, and, therefore, bone orthopedic and therapeutic applications.
4. Discussion
The wide range of potential applications of NPs in medicine is strictly related to their
physiochemical features and surface charge along with shape, size, and concentration. However,
the well-demonstrated, broad-spectrum antibacterial properties of NPs against Gram-positive and
negative microorganisms make them valid candidates to fight infections in the orthopedic field, and
particularly in implant-related bone infections. The major mechanisms of action of NPs are explicated
by metal ion release, oxidative stress induction, or non-oxidative mechanisms. Thus, the antimicrobial
activities determine the penetration and disruption of the bacterial cell, the generation of ROS and
intracellular effects, i.e., interactions with DNA and proteins.
Unfortunately, all these mechanisms also act towards cells present in the human body. This implies
the need to have a deeper insight into the toxic effects of NPs, mainly related to the non-specific
binding to host cells, biological fluids and the consequent accumulation in tissues and organs of
living organisms. Despite several in vitro studies that demonstrate the balance between antimicrobial
activities and eukaryotic cell safety, the wide range of NPs concentrations, exposure time and tested
cell lineages represent the major drawback in obtaining consistent and reproducible results. More
importantly, the precise investigation of NP biodistribution and pharmacokinetics is mandatory for
their translatability to clinics. However, similar limitations of in vitro evaluations can be derived from
studies that extensively investigated the systemic toxicity of NPs on the metabolism or immune system
of rodents treated through the intravenous, dermal, subcutaneous, inhalation, intraperitoneal, and oral
routes [111]. Thus, further studies should be performed to better correlate the in vitro with the in vivo
effects of NPs, also concerning the synthesis process.
Indeed, the fabrication process of NPs deserves to be taken into account because it has an influence
on the potential toxicity of these molecules as well as on the costs related to NP production. NPs are
usually generated by chemical, physical, or biological synthesis, of which the chemical synthesis often
showed cytotoxic effects due to the presence of agents used in the generation process. In contrast,
physical methods (i.e., laser-synthesized NPs) could have greater success in medical applications
because of the absence of residual toxic compounds [112]. Similarly, the green biosynthesis of NPs
from natural products could be an alternative method to develop environmentally friendly and
non-toxic NPs exploiting renewable materials [13]. The green synthesis of NPs results in a product
with enhanced stability and biocompatibility, due to the possibility to vary the range of sizes, shapes,
and compositions of biosynthesized NPs with minor use of hazardous chemicals [113]. Several
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biological materials such as algae, as well as leaves, roots, and tubers, have demonstrated antibacterial
power [114]. For example, green tea extract from Camellia sinensis leaves was exploited to produce Ag
NPs [115], while Mentha piperita leaf extract included both Au and Ag NPs with antibacterial properties
against both Gram-positive and negative bacteria [116]. The green synthesis of antibacterial NPs is also
a cost-effective strategy that allows the production of several transition metal NPs without resorting to
the traditional chemical synthesis, contributing to the protection of the ecosystem [117]. The use of
maize waste materials, for example, is a profitable and eco-friendly strategy for NP synthesis.
It is implicit that currently the in vitro and in vivo studies furnish the results of NPs in their free
form and that their conjugation with implant or construct surfaces can modify either the cultured
cells or the host response. Indeed, one of the main strategies to be employed to diminish the potential
toxicity of NPs is their use as coating materials for orthopedic implants. In fact, linking NPs to
the surface of implant devices as well as to various natural or polymer structures could generate
suitable biocompatible materials able to enhance NP stability, biological fluid dispensability, and
biocompatibility. To spatially confine and stabilize NPs to avoid their aggregation due to their surface
charge and electric potential, capping agents (e.g., citrate, chitosan, polyethylene glycol (PEG), and
hydroxyapatite, etc.) have been proposed. Ag NPs stabilized with citrate or chitosan reported
an enhanced capability in killing bacteria compared to Ag NPs alone, mainly due to an increased
production of Ag ions from the NPs [118]. Conversely, Ag NPs linked to hydroxyapatite were able
to release a large number of ions able to counteract bacterial colonization at the very beginning of
their release [119]. Similarly, PEGylated NPs led to a lower antimicrobial activity, thus reducing their
potential use for this purpose [118]. Whilst this approach could represent an advantage in the biosafety
of NPs, their antimicrobial properties and uncontrolled ion release could be affected when NPs are
stably linked to the surface of orthopedic implant materials.
Regardless of their form, the antibacterial efficacy of NPs either free or conjugated with
implantable devices relies on the balance between risks and benefits, as for any other drugs. In this
context, the assessment of a therapeutic window is mandatory for a more conscientious use of
nanoparticles in clinics. Indeed, the therapeutic dose should be sufficiently high to guarantee cytotoxic
effects against prokaryotic cells, but not to eukaryotic cells. Indeed, side effects related to the use of
NPs are not only locally confined to surrounding cells, but major systems (i.e., respiratory, neurological
and circulatory) might also be affected [120].
Furthermore, the concentration should be sufficiently low to guarantee the safety while
discouraging the development of the antimicrobial resistance. Indeed, the plasticity of the bacterial
genome confers to microorganisms the ability to tolerate the stressful stimuli caused by the presence of
a few ions or NPs. This event might result in the modification of phenotypic and genotypic features
of bacteria, such as the ability to repair DNA damages or to produce enzymes able to counteract the
nitrosative stress [121].
While it could be very easy to measure out the levels of free NPs in a living organism, the detection
of ions or molecules released from the surface of implants might be demanding and subjected to the
host physio- or pathological microenvironment [122]. Furthermore, the release of the aforementioned
particles from implant devices cannot be controlled over time, thus resulting in chronic NP exposure
and intake.
Nonetheless, the nano-sized modification of implant surfaces must be analyzed for corrosion
resistance in order to guarantee some tribological characteristics. Metal implants are protected from
corrosion by a surface oxide layer; however, mechanical stress may defeat this protection, thus
leading to the release of detrimental metallic particles. Indeed, it is well-known that any metal
implant undergoes mechanisms able to produce nanoscopic metal wear debris and corrosion products
(25–36 nm), causing the elevation of ion levels correlated to local and systemic adverse effects
(i.e., inflammation, hypersensitivity, osteolysis, etc.) [123]. Even if a milder antimicrobial and cytotoxic
activity of TiO2 compared to Ag has been demonstrated, the need to expose the material to UV light
in order to activate the metal oxide limits the possible use of TiO2 NPs conjugated to orthopedic
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devices. Although titanium alloys are considered inert, they can be a source of TiO2 NPs from bone
implants that have been recently demonstrated to impair bone formation and to interfere with bone
resorption at the site of repair, thus leading to aseptic loosening of implants and pain [124]. Differently,
Zr demonstrated promising features for its use in the orthopedic field through the ability to support a
better integration with biological systems without the generation of wear debris from the surface of
nanostructured zirconia implants.
Among several antibacterial NPs, the noble metals, like Ag and Au, have gained much attention.
Indeed, nanomaterials are increasingly an integral part of orthopedic implants and scaffolds. The main
advantage of such solutions is the ability to manipulate the properties of biomaterial surfaces on a
nanometric scale. Thanks to Ag antimicrobial properties per se or as NPs, market products containing
Ag NPs are used for wound care (Acticoat) or catheters (I-Flow SilverSoaker Nanosilver), as reported
in “The global nanomaterials market, 2010–2025”. In the patent by Yan and colleagues (US 6379712 B1),
the preparation of granules coated with Ag NPs acting as an antibacterial and antifungal agent has
been described, thus opening the use of these NPs as a component of various types of preparations.
The use of Ag NPs to impede the attachment of bacteria to the surface of dental implants is also known
(Patent US 2007/0293799 A1) [79]. However, nowadays no clinical trials evaluating the use of transition
metal NPs in orthopedics exist, only a few trials are currently investigating the use of Ag, TiO2, and
Zn NPs in dentistry [125]. From this analysis it appears that the need for the commercial use of NPs is
clearly faster than the response of the research on the toxicity of these nanomaterials [126]. Indeed, NP
aggregation due to their high surface energy and toxic nature limits their use. Thus, attention should
be given to the interaction of NPs and biological fluids, which supports their aggregation and reduces
the possibility to correctly evaluate the NP concentration within organisms. Concrete examples of the
underestimated toxicity of NPs led to treatment of burned patients with ionic Ag, causing reactions
of hypersensitivity [127]. In orthopedics, some studies reported concentrations of silver 1000 times
the serum baseline that led to neuropathy and muscle paralysis in patients who underwent total hip
arthroplasty and were treated with silver-impregnated cement [128,129]. To the best of our knowledge,
only one study evaluated in vivo the effects of Ag NPs as a titanium-based implant coating to prevent
staphylococcal biofilm in orthopedics [130]. In the study, the medullary cavity of rat femur was
inoculated with S. aureus ATCC 35984 and Ag NPs immobilized or pure titanium K-wire was inserted
into the cavity. Ag NPs were found to reduce the risk of implant-associated peri-prosthetic infection.
On the other hand, Au has a good balance between its antimicrobial activity in the form of
NPs and cytocompatibility, because of the inability to generate ROS. Furthermore, recently, a new
class of drugs for rheumatoid arthritis has been developed, exploiting the Au NP ability to invade
macrophages and stop them from producing inflammation without killing them. The researchers
found that by reducing gold into NPs (50 nm), more gold was absorbed into the cells, with much less
toxicity in the case of rheumatoid arthritis [131]. Again, Au NPs have been widely used in imaging
and diagnosis of many diseases [132], or as intravenous contrast agents for imaging and noninvasive
detection of lung cancer and many other topics [133]. Even if the use of Au NPs is not yet approved by
the US Food and Drug Administration, there are clinical trials currently evaluating the use Au NPs in
many different clinical fields, as aforementioned in immunotherapy (e.g., rheumatoid arthritis) and
imaging [125,134]. This scenario reports a debatable situation. The controversy is well explained in the
findings of Villiers et al., who analyzed the viability of murine dendritic cells incubated in the presence
of Au NPs, showing that these particles are not cytotoxic, even at high concentrations. However, the
analysis of the cells revealed significant amounts of Au NPs in endocytic compartments and a higher
secretion of cytokines, thus demonstrating a potential adverse event in the immune response [135].
Although in vitro tests are useful to screen compounds and to recognize effects induced on cells,
they may not be sufficient to define safe exposure limits.
Finally, it must be taken into account that excessive levels of essential trace elements are
harmful to living organisms, despite their vital role [13], thus discouraging the use of Cu, Zn,
and Fe for medical purposes. Indeed, these elements are known to have a significant influence
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on physiological mechanisms involved in cellular metabolism, immune function, wound healing,
protein synthesis and acting as antioxidant [136]. An imbalance of the physiological presence of these
trace elements could lead to the development of severe human diseases, including cancer, hepatic
and neurodegenerative diseases. In particular, Fe excess has been demonstrated to be associated
with the pathogenesis of Alzheimer and Parkinson’s diseases interacting with amyloid β-peptides.
An exaggerated abundance of Cu impairs the mitochondrial respiratory chain, affecting the calcium
retention capacity of cardiomyocytes [137]. Finally, Zn is the second most abundant transition metal
in organisms after Fe, and in contrast to Fe and Cu, it is redox-inert despite numerous findings that
demonstrated a pro-oxidant role causing cell death [138,139]. An excessive absorption of Zn suppresses
physiological Fe and Cu intake, despite that Zn accumulation is very rare [136].
According to this premise, nowadays, the research community perfectly responded to the
antibacterial advantages of using NPs, in particular, Ag NPs, but the unknown-or better-incomplete
known about the toxic effects related to these nanomaterials makes it necessary to conduct further
research on the toxicity of NPs in living organisms. The basic question to be addressed is: how
toxic are NPs at the potential concentrations at which they might be used for therapeutics? In
addition, at present, even if several reports have been published, the problem remains basically
unsolved. Thus, evaluation of the safety of nanomaterials is mandatory to balance the risks and
benefits for their successful development and translatability. Specifically, in the case of use of NPs as
antimicrobial coatings on implant devices, the question of their toxicity becomes challenging due to
the great difficulty to evaluate the released amount after implantation in living organisms. Moreover,
an undervalued aspect is the clearance of NPs from the body after their therapeutic effect is concluded.
In this respect, it is also important to state that there is a diversity between cytotoxicity and cellular
damage. Indeed, NPs without or with poor cytotoxicity may determine cellular damage. On the basis
of this scenario, a common and standardized approach to investigate the effective level of toxicity in
different experimental setups is urgently required, starting from the physical and chemical properties
of NPs, through the in vitro results to their effects in vivo.
Despite the promising future of Ag- and Au NPs as antimicrobial strategies in orthopedics, there
are many essential issues to be addressed, such as NP stabilization onto the implant devices, the
therapeutic window within which NPs can be employed in the absence of side-effects, the long-term
fate and effects of NPs in the organisms to be used in humans without risks. Considering this aspect, a
complete preclinical evaluation of NP safety, toxicology and kinetics should be dutifully verified in
in vivo models.
Nevertheless, although the toxicity and persistence of NPs within filter organs are not well
verified, nowadays, several basic research on NP development and potential use is published in top
journals by overemphasizing NP potentialities, but without any existing potential of translation in
clinics. In fact, no NP-based antibacterial drugs have currently achieved FDA approval [100], despite
the emergence of a variety of nano-functionalized materials.
Thus, the imbalance between advantages and disadvantages in using NPs raises this question:
why is there this trend? Furthermore, the more complex the nanomaterials, and the efforts to make
them more biocompatible, the higher will be the costs of their production with much reduced potential
for their commercialization. This is mainly true in the case of orthopedic infections compared to
oncologic or lethal diseases, in which NPs could represent an innovative weapon in the absence of
other strategies.
In this context, the main purpose of this review article is to analyze the wide panorama of
transition metal-derived NPs of particular interest as possible coating materials for prosthetic implants
in order to fight or prevent infections. Rather than making a systematic review of the most recent
work, here we highlighted how the non-standardized use of metal NPs in research studies prevents the
possibility of reaching a general conclusion regarding the effective safety of these NPs. Moreover, this
analysis wants to caution the readers regarding regulations advancing the development and use of NPs.
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Hopefully, future work in vivo and clinical trials will support and regulate the use of nano-coatings to
guarantee a safer use of this promising approach against antibiotic-resistant microorganisms.
Author Contributions: Conceptualization, L.D. and G.B.; literature search and analysis, M.B., A.B.L. and F.G.;
original draft preparation, M.B., A.L. and F.G.; writing—review and editing, M.B. and A.L.; supervision, G.B.;
manuscript critical revision, L.D. and G.B.
Funding: This research was supported by the Italian Ministry of Health (RC Project).
Acknowledgments: The authors would like to thank Archna Bhandari (Biopharma Navigator, Expert System) for
technical support and use of the software.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Ventola, C.L. The antibiotic resistance crisis: Part 1: Causes and threats. Pram. Ther. 2015, 40, 277–283.
2. Pechère, J.C. Patients’ interviews and misuse of antibiotics. Clin. Infect. Dis. 2001, 15, S170–S173. [CrossRef]
[PubMed]
3. Norrby, S.R.; Nord, C.E.; Finch, R. European Society of Clinical Microbiology and Infectious Diseases. Lack
of development of new antimicrobial drugs: A potential serious threat to public health. Lancet Infect. Dis.
2005, 5, 115–119. [CrossRef]
4. Ribeiro, M.; Monteiro, F.J.; Ferraz, M.P. Infection of orthopedic implants with emphasis on bacterial adhesion
process and techniques used in studying bacterial-material interactions. Biomatter 2012, 2, 176–194. [CrossRef]
[PubMed]
5. Beyth, N.; Houri-Haddad, Y.; Domb, A.; Khan, W.; Hazan, R. Alternative antimicrobial approach:
Nano-antimicrobial materials. Evid. Based Complement. Alternat. Med. 2015, 2015, 246012. [CrossRef]
[PubMed]
6. Peersman, G.; Laskin, R.; Davis, J.; Peterson, M. Infection in total knee replacement: A retrospective review
of 6489 total knee replacements. Clin. Orthop. Relat. Res. 2001, 392, 15–23. [CrossRef]
7. Marculescu, C.E.; Berbari, E.F.; Hanssen, A.D.; Steckelberg, J.M.; Harmsen, S.W.; Mandrekar, J.N.;
Osmon, D.R. Outcome of prosthetic joint infections treated with debridement and retention of components.
Clin. Infect. Dis. 2006, 42, 471–478. [CrossRef]
8. Trampuz, A.; Zimmerli, W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis.
Curr. Infect. Dis. Rep. 2008, 10, 394–403. [CrossRef]
9. Gristina, A.G.; Naylor, P.T.; Myrvik, Q. The race for the surface: Microbes, tissue cells, and biomaterials.
In Molecular Mechanisms of Microbial Adhesion, 1st ed.; Switalski, L., Höök, M., Beachey, E., Eds.; Springer:
New York, NY, USA, 1989; pp. 177–211. ISBN 978-1-4612-8169-6.
10. Koseki, H.; Yonekura, A.; Shida, T.; Yoda, I.; Horiuchi, H.; Morinaga, Y.; Yanagihara, K.; Sakoda, H.; Osaki, M.;
Tomita, M. Early staphylococcal biofilm formation on solid orthopaedic implant materials: In vitro study.
PLoS ONE 2014, 9, e107588. [CrossRef]
11. Kırmusaog˘lu, S. Staphylococcal biofilms: Pathogenicity, mechanism and regulation of biofilm formation
by quorum-sensing system and antibiotic resistance mechanisms of biofilm-embedded microorganisms.
In Microbial Biofilms Importance and Applications, 1st ed.; Dhanasekaran, D., Ed.; IntechOpen: London, UK,
2016; ISBN 978-953-51-2436-8. [CrossRef]
12. Hall-Stoodley, L.; Costerton, J.W.; Stoodley, P. Bacterial biofilms: From the natural environment to infectious
diseases. Nat. Rev. Microbiol. 2004, 2, 95–108. [CrossRef]
13. Santos, C.L.; Albuquerque, A.J.R.; Sampaio, F.C.; Keyson, D. Nanomaterials with Antimicrobial Properties:
Applications in Health Sciences. In Microbial Pathogens and Strategies for Combating Them: Science, Technology
and Education, 1st ed.; Méndez-Vilas, A., Ed.; Formatex Research Center: Badajoz, Spain, 2013; pp. 143–154.
ISBN 978-84-939843-9-7.
14. Li, X.; Robinson, S.M.; Gupta, A.; Saha, K.; Jiang, Z.; Moyano, D.F.; Sahar, A.; Riley, M.A.; Rotello, V.M.
Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano
2014, 8, 10682–10686. [CrossRef] [PubMed]
Materials 2019, 12, 314 14 of 20
15. Mohamed, M.M.; Fouad, S.A.; Elshoky, H.A.; Mohammed, G.M.; Salaheldin, T.A. Antibacterial effect of gold
nanoparticles against Corynebacterium pseudotuberculosis. Int. J. Vet. Sci. Med. 2017, 5, 23–29. [CrossRef]
[PubMed]
16. Markowska, K.; Grudniak, A.M.; Wolska, K.I. Silver nanoparticles as an alternative strategy against bacterial
biofilms. Acta Biochim. Pol. 2013, 60, 523–530. [PubMed]
17. Yu, Q.; Li, J.; Zhang, Y.; Wang, Y.; Liu, L.; Li, M. Inhibition of gold nanoparticles (Au NPs) on pathogenic
biofilm formation and invasion to host cells. Sci. Rep. 2016, 25, 26667. [CrossRef] [PubMed]
18. Miao, L.; Wang, C.; Hou, J.; Wang, P.; Ao, Y.; Li, Y.; Geng, N.; Yao, Y.; Lv, B.; Yang, Y.; et al. Aggregation and
removal of copper oxide (CuO) nanoparticles in wastewater environment and their effects on the microbial
activities of wastewater biofilms. Bioresour. Technol. 2016, 216, 537–544. [CrossRef] [PubMed]
19. Wang, L.; Hu, C.; Shao, L. The antimicrobial activity of nanoparticles: Present situation and prospects for the
future. Int. J. Nanomed. 2017, 14, 1227–1249. [CrossRef] [PubMed]
20. Mazaheri, M.; Eslahi, N.; Ordikhani, F.; Tamjid, E.; Simchi, A. Nanomedicine applications in orthopedic
medicine: State of the art. Int. J. Nanomed. 2015, 28, 6039–6053. [CrossRef]
21. Franci, G.; Falanga, A.; Galdiero, S.; Palomba, L.; Rai, M.; Morelli, G.; Galdiero, M. Silver nanoparticles as
potential antibacterial agents. Molecules 2015, 20, 8856–8874. [CrossRef] [PubMed]
22. Dakal, T.C.; Kumar, A.; Majumdar, R.S.; Yadav, V. Mechanistic Basis of Antimicrobial Actions of Silver
Nanoparticles. Front. Microbiol. 2016, 16, 1–17. [CrossRef]
23. Gottenbos, B.; Grijpma, D.W.; van der Mei, H.C.; Feijen, J.; Busscher, H.J. Antimicrobial effects of positively
charged surfaces on adhering Gram-positive and Gram-negative bacteria. J. Antimicrob. Chemother. 2001, 48,
7–13. [CrossRef]
24. Lara, H.H.; Ayala-Nuñez, N.V.; Ixtepan-Turrent, L.; Rodriguez-Padilla, C. Bactericidal effect of silver
nanoparticles against multidrug-resistant bacteria. World J. Microbiol. Biotechnol. 2010, 26, 615–621. [CrossRef]
25. Qing, Y.; Cheng, L.; Li, R.; Liu, G.; Zhang, Y.; Tang, X.; Wang, J.; Liu, H.; Qin, Y. Potential antibacterial
mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification
technologies. Int. J. Nanomed. 2018, 5, 3311–3327. [CrossRef] [PubMed]
26. Flores, C.Y.; Miñán, A.G.; Grillo, C.A.; Salvarezza, R.C.; Vericat, C.; Schilardi, P.L. Citrate-capped silver
nanoparticles showing good bactericidal effect against both planktonic and sessile bacteria and a low
cytotoxicity to osteoblastic cells. ACS Appl. Mater. Interfaces 2013, 5, 3149–3159. [CrossRef] [PubMed]
27. Clement, J.L.; Jarrett, P.S. Antibacterial silver. Met. Based Drugs 1994, 1, 467–482. [CrossRef] [PubMed]
28. Panácek, A.; Kolár, M.; Vecerová, R.; Prucek, R.; Soukupová, J.; Krystof, V.; Hamal, P.; Zboril, R.; Kvítek, L.
Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009, 30, 6333–6340. [CrossRef]
[PubMed]
29. Schmidt-Braekling, T.; Streitbuerger, A.; Gosheger, G.; Boettner, F.; Nottrott, M.; Ahrens, H.; Dieckmann, R.;
Guder, W.; Andreou, D.; Hauschild, G.; et al. Silver-coated megaprostheses: Review of the literature. Eur. J.
Orthop. Surg. Traumatol. 2017, 27, 483–489. [CrossRef]
30. Konop, M.; Damps, T.; Misicka, A.; Rudnicka, L. Certain Aspects of Silver and Silver Nanoparticles in Wound
Care: A Minireview. J. Nanomater. 2016, 2016, 1–10. [CrossRef]
31. Burdus, el, A.C.; Gherasim, O.; Grumezescu, A.M.; Mogoantă, L.; Ficai, A.; Andronescu, E. Biomedical
Applications of Silver Nanoparticles: An Up-to-Date Overview. Nanomaterials 2018, 8, 681. [CrossRef]
32. Cavaliere, E.; De Cesari, S.; Landini, G.; Riccobono, E.; Pallecchi, L.; Rossolini, G.M.; Gavioli, L. Highly
bactericidal Ag nanoparticle films obtained by cluster beam deposition. Nanomedicine 2015, 11, 1417–1423.
[CrossRef]
33. Benetti, G.; Cavaliere, E.; Brescia, R.; Salassi, S.; Ferrando, R.; Vantomme, A.; Pallecchi, L.; Pollini, S.;
Boncompagni, S.; Fortuni, B.; et al. Tailored multi-elemental Nanoparticles for wide spectrum antibacterial
coatings. Nanoscale 2019. [CrossRef]
34. Cavaliere, E.; Benetti, G.; Van Bael, M.; Winckelmans, N.; Bals, S.; Gavioli, L. Exploring the Optical
and Morphological Properties of Ag and Ag/TiO2 Nanocomposites Grown by Supersonic Cluster Beam
Deposition. Nanomaterials 2017, 13, 442. [CrossRef] [PubMed]
35. Benetti, G.; Caddeo, C.; Melis, C.; Ferrini, G.; Giannetti, C.; Winckelmans, N.; Bals, S.; Van Bael, M.J.;
Cavaliere, E.; Gavioli, L.; et al. Bottom-Up Mechanical Nanometrology of Granular Ag Nanoparticles Thin
Films. J. Phys. Chem. C 2017, 121, 22434–22441. [CrossRef]
Materials 2019, 12, 314 15 of 20
36. Benetti, G.; Cavaliere, E.; Canteri, A.; Landini, G.; Rossolini, G.M.; Pallecchi, L.; Chiodi, M.; Van Bael, M.J.;
Winckelmans, N.; Bals, S.; et al. Direct synthesis of antimicrobial coatings based on tailored bi-elemental
nanoparticles. APL Mater. 2017, 5, 036105. [CrossRef]
37. Peli, S.; Cavaliere, E.; Benetti, G.; Gandolfi, M.; Chiodi, M.; Cancellieri, C.; Giannetti, C.; Ferrini, G.; Gavioli, L.;
Banfi, F. Mechanical Properties of Ag Nanoparticle Thin Films Synthesized by Supersonic Cluster Beam
Deposition. J. Phys. Chem. C 2016, 120, 4673–4681. [CrossRef]
38. Karak, N. Silver Nanomaterials and Their Polymer Nanocomposites. In Nanomaterials and Polymer
Nanocomposites, 1st ed.; Karak, N., Ed.; Elsevier: Amsterdam, The Netherlands, 2019; pp. 47–89.
ISBN 978-0-12-814615-6.
39. Tran, Q.H.; Nguyen, V.Q.; Le, A.T. Silver nanoparticles: Synthesis, properties, toxicology, applications and
perspectives. Adv. Nat. Sci. Nanosci. Nanotechnol. 2013, 4, 033001. [CrossRef]
40. Raza, M.A.; Kanwal, Z.; Rauf, A.; Sabri, A.N.; Riaz, S.; Naseem, S. Size- and shape-dependent antibacterial
studies of silver nanoparticles synthesized by wet chemical routes. Nanomaterials 2016, 6, 74. [CrossRef]
[PubMed]
41. Pal, S.; Tak, Y.K.; Song, J.M. Does the antibacterial activity of silver nanoparticles depend on the shape of the
nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73,
1712–1720. [CrossRef]
42. Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; et al.
Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2007, 3, 95–101. [CrossRef]
43. Naqvi, S.Z.; Kiran, U.; Ali, M.I.; Jamal, A.; Hameed, A.; Ahmed, S.; Ali, N. Combined efficacy of biologically
synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int. J. Nanomed.
2013, 8, 3187–3195. [CrossRef]
44. Randall, C.P.; Gupta, A.; Jackson, N.; Busse, D.; O’Neill, A.J. Silver resistance in Gram-negative bacteria:
A dissection of endogenous and exogenous mechanisms. J. Antimicrob. Chemother. 2015, 70, 1037–1046.
[CrossRef]
45. Gupta, A.; Matsui, K.; Lo, J.F.; Silver, S. Molecular basis for resistance to silver cations in Salmonella. Nat. Med.
1999, 5, 183–188. [CrossRef] [PubMed]
46. Panácˇek, A.; Kvítek, L.; Smékalová, M.; Vecˇerˇová, R.; Kolárˇ, M.; Röderová, M.; Dycˇka, F.; Šebela, M.;
Prucek, R.; Tomanec, O.; et al. Bacterial resistance to silver nanoparticles and how to overcome it.
Nat. Nanotechnol. 2017, 13, 65–71. [CrossRef] [PubMed]
47. Cameron, S.J.; Hosseinian, F.; Willmore, W.G. A Current Overview of the Biological and Cellular Effects of
Nanosilver. Int. J. Mol. Sci. 2018, 12, 2030. [CrossRef] [PubMed]
48. Albers, C.E.; Hofstetter, W.; Siebenrock, K.A.; Landmann, R.; Klenke, F.M. In vitro cytotoxicity of silver
nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 2013, 7, 30–36.
[CrossRef] [PubMed]
49. Castiglioni, S.; Cazzaniga, A.; Locatelli, L.; Maier, J.A.M. Silver Nanoparticles in Orthopedic Applications:
New Insights on Their Effects on Osteogenic Cells. Nanomaterials 2017, 27, 124. [CrossRef]
50. Flores-López, L.Z.; Espinoza-Gómez, H.; Somanathan, R. Silver nanoparticles: Electron transfer, reactive
oxygen species, oxidative stress, beneficial and toxicological effects. Mini review. J. Appl. Toxicol. 2019, 39,
16–26. [CrossRef] [PubMed]
51. Politano, A.D.; Campbell, K.T.; Rosenberger, L.H.; Sawyer, R.G. Use of silver in the prevention and treatment
of infections: Silver review. Surg. Infect. 2013, 14, 8–20. [CrossRef] [PubMed]
52. Cui, Y.; Zhao, Y.; Tian, Y.; Zhang, W.; Lü, X.; Jiang, X. The molecular mechanism of action of bactericidal gold
nanoparticles on Escherichia coli. Biomaterials 2012, 33, 2327–2333. [CrossRef]
53. Zhang, Y.; Shareena Dasari, T.P.; Deng, H.; Yu, H. Antimicrobial Activity of Gold Nanoparticles and Ionic
Gold. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2015, 33, 286–327. [CrossRef]
54. Grzelczak, M.; Pérez-Juste, J.; Mulvaney, P.; Liz-Marzán, L.M. Shape control in gold nanoparticles synthesis.
Chem. Soc. Rev. 2008, 37, 1783–1791. [CrossRef]
55. Wani, I.A.; Ahmad, T.; Manzoor, N. Size and shape dependant antifungal activity of gold nanoparticles:
A case study of Candida. Colloids Surf. B Biointerfaces 2013, 1, 162–170. [CrossRef] [PubMed]
56. Norman, R.S.; Stone, J.W.; Gole, A.; Murphy, C.J.; Sabo-Attwood, T.L. Targeted photothermal lysis of the
pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods. Nano Lett. 2008, 8, 302–306. [CrossRef]
[PubMed]
Materials 2019, 12, 314 16 of 20
57. Nirmala, G.A.; Pandian, K. Antibacterial efficacy of aminoglycosidic antibiotics protected gold
nanoparticles-A brief study. Colloids Surf. A Physicochem. Eng. Asp. 2007, 297, 63–70. [CrossRef]
58. Zawrah, M.F.; El-Moez, S.I.A. Antimicrobial activities of gold nanoparticles against major foodborne
pathogens. Life Sci. J. 2011, 8, 37–44.
59. Tsai, S.W.; Liaw, J.W.; Kao, Y.C.; Huang, M.Y.; Lee, C.Y.; Rau, L.R.; Huang, C.Y.; Wei, K.C.; Ye, T.C. Internalized
gold nanoparticles do not affect the osteogenesis and apoptosis of MG63 osteoblast-like cells: A quantitative,
in vitro study. PLoS ONE 2013, 8, e76545. [CrossRef] [PubMed]
60. Zhang, D.; Liu, D.; Zhang, J.; Fong, C.; Yang, M. Gold nanoparticles stimulate differentiation and
mineralization of primary osteoblasts through the ERK/MAPK signaling pathway. Mater. Sci. Eng. C
Mater. Biol. Appl. 2014, 42, 70–77. [CrossRef] [PubMed]
61. Li, J.; Li, J.J.; Zhang, J.; Wang, X.; Kawazoe, N.; Chen, G. Gold nanoparticle size and shape influence on
osteogenesis of mesenchymal stem cells. Nanoscale 2016, 8, 7992–8007. [CrossRef] [PubMed]
62. Yang, T.; Qian, S.; Qiao, Y.; Liu, X. Cytocompatibility and antibacterial activity of titania nanotubes
incorporated with gold nanoparticles. Colloids Surf. B Biointerfaces 2016, 1, 597–606. [CrossRef]
63. Liu, R.; Memarzadeh, K.; Chang, B.; Zhang, Y.; Ma, Z.; Allaker, R.P.; Ren, L.; Yang, K. Antibacterial effect of
copper-bearing titanium alloy (Ti-Cu) against Streptococcus mutans and Porphyromonas gingivalis. Sci. Rep.
2016, 6, 29985. [CrossRef]
64. Goudouri, O.M.; Kontonasaki, E.; Lohbauer, U.; Boccaccini, A.R. Antibacterial properties of metal and
metalloid ions in chronic periodontitis and peri-implantitis therapy. Acta Biomater. 2014, 10, 3795–3810.
[CrossRef]
65. Su, Y.; Zheng, X.; Chen, Y.; Li, M.; Liu, K. Alteration of intracellular protein expressions as a key mechanism
of the deterioration of bacterial denitrification caused by copper oxide nanoparticles. Sci. Rep. 2015, 5, 15824.
[CrossRef] [PubMed]
66. Wu, C.; Zhou, Y.; Xu, M.; Han, P.; Chen, L.; Chang, J.; Xiao, Y. Copper-containing mesoporous bioactive
glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial
activity. Biomaterials 2013, 34, 422–433. [CrossRef] [PubMed]
67. Alzahrani, E.; Ahmed, R.A. Synthesis of Copper Nanoparticles with Various Sizes and Shapes: Application
as a Superior Non-Enzymatic Sensor and Antibacterial Agent. Int. J. Electrochem. Sci. 2016, 11, 4712–4723.
[CrossRef]
68. EL-Mekkawia, D.M.; Selima, M.M.; Nehad Hamdib, M.M.; Hassanc, S.A.; Ezzatc, A. Studies on the influence
of the physicochemical characteristics of nanostructured copper, zinc and magnesium oxides on their
antibacterial activities. J. Environ. Chem. Eng. 2018, 6, 5608–5615. [CrossRef]
69. Ren, G.; Hu, D.; Cheng, E.W.C.; Vargas-Reus, M.A.; Reip, P.; Allaker, R.P. Characterisation of copper oxide
nanoparticles for antimicrobial applications. Int. J. Antimicrob. Agents 2009, 33, 587–590. [CrossRef] [PubMed]
70. Eshed, M.; Lellouche, J.; Matalon, S.; Gedanken, A.; Banin, E. Sonochemical coatings of ZnO and CuO
nanoparticles inhibit Streptococcus mutans biofilm formation on teeth model. Langmuir 2012, 28, 12288–12295.
[CrossRef] [PubMed]
71. Zhang, X.; Li, J.; Wang, X.; Wang, Y.; Hang, R.; Huang, X.; Tang, B.; Chu, P.K. Effects of copper nanoparticles
in porous TiO2 coatings on bacterial resistance and cytocompatibility of osteoblasts and endothelial cells.
Mater. Sci. Eng. C 2018, 1, 110–120. [CrossRef]
72. Shi, F.; Liu, Y.; Zhi, W.; Xiao, D.; Li, H.; Duan, K.; Qu, S.; Weng, J. The synergistic effect of
micro/nano-structured and Cu2+-doped hydroxyapatite particles to promote osteoblast viability and
antibacterial activity. Biomed. Mater. 2017, 12, 035006. [CrossRef]
73. Itabashi, T.; Narita, K.; Ono, A.; Wada, K.; Tanaka, T.; Kumagai, G.; Yamauchi, R.; Nakane, A.; Ishibashi, Y.
Bactericidal and antimicrobial effects of pure titanium and titanium alloy treated with short-term, low-energy
UV irradiation. Bone Jt. Res. 2017, 6, 108–112. [CrossRef]
74. Koseki, H.; Asahara, T.; Shida, T.; Yoda, I.; Horiuchi, H.; Baba, K.; Osaki, M. Clinical and histomorphometrical
study on titanium dioxide-coated external fixation pins. Int. J. Nanomed. 2013, 8, 593–599. [CrossRef]
75. Liu, Y.; Wang, X.; Yang, F.; Yang, X. Excellent antimicrobial properties of mesoporous anatase TiO2 and
Ag/TiO2 composite films. Microporous Mesoporous Mater. 2008, 114, 431–439. [CrossRef]
76. Foster, H.A.; Ditta, I.B.; Varghese, S.; Steele, A. Photocatalytic disinfection using titanium dioxide: Spectrum
and mechanism of antimicrobial activity. Appl. Microbiol. Biotechnol. 2011, 90, 1847–1868. [CrossRef]
[PubMed]
Materials 2019, 12, 314 17 of 20
77. Visai, L.; De Nardo, L.; Punta, C.; Melone, L.; Cigada, A.; Imbriani, M.; Arciola, C.R. Titanium oxide
antibacterial surfaces in biomedical devices. Int. J. Artif. Organs 2011, 34, 929–946. [CrossRef] [PubMed]
78. Hirakawa, K.; Mori, M.; Yoshida, M.; Oikawa, S.; Kawanishi, S. Photo-irradiated titanium dioxide catalyzes
site specific DNA damage via generation of hydrogen peroxide. Free Radic. Res. 2004, 38, 439–447. [CrossRef]
[PubMed]
79. Yao, J.J.; Lewallen, E.A.; Trousdale, W.H.; Xu, W.; Thaler, R.; Salib, C.G.; Reina, N.; Abdel, M.P.; Lewallen, D.G.;
van Wijnen, A.J. Local cellular responses to titanium dioxide from orthopedic implants. Biores. Open Access
2017, 6, 94–103. [CrossRef] [PubMed]
80. Hanley, C.; Thurber, A.; Hanna, C.; Punnoose, A.; Zhang, J.; Wingett, D.G. The Influences of Cell Type and
ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction. Nanoscale Res. Lett. 2009, 4,
1409–1420. [CrossRef] [PubMed]
81. Sirelkhatim, A.; Mahmud, S.; Seeni, A.; Kaus, N.H.M.; Ann, L.C.; Bakhori, S.K.M.; Mohamad, D. Review on
Zinc Oxide Nanoparticles: Antibacterial Activity and Toxicity Mechanism. Nanomicro Lett. 2015, 7, 219–242.
[CrossRef] [PubMed]
82. Blencowe, D.K.; Morby, A.P. Zn(II) metabolism in prokaryotes. FEMS Microbiol. Rev. 2003, 27, 291–311.
[CrossRef]
83. Hobman, J.L.; Crossman, L.C. Bacterial antimicrobial metal ion resistance. J. Med. Microbiol. 2015, 64, 471–497.
[CrossRef]
84. Jones, N.; Ray, B.; Ranjit, K.T.; Manna, A.C. Antibacterial activity of ZnO nanoparticle suspensions on a
broad spectrum of microorganisms. FEMS Microbiol. Lett. 2008, 279, 71–76. [CrossRef]
85. Xie, Y.; He, Y.; Irwin, P.L.; Jin, T.; Shi, X. Antibacterial activity and mechanism of action of zinc oxide
nanoparticles against Campylobacter jejuni. Appl. Environ. Microbiol. 2011, 77, 2325–2331. [CrossRef]
[PubMed]
86. Reddy, K.M.; Feris, K.; Bell, J.; Wingett, D.G.; Hanley, C.; Punnoose, A. Selective toxicity of zinc oxide
nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 2007, 24, 2139021–2139023. [CrossRef]
[PubMed]
87. Memarzadeh, K.; Sharili, A.S.; Huang, J.; Rawlinson, S.C.; Allaker, R.P. Nanoparticulate zinc oxide as a
coating material for orthopedic and dental implants. J. Biomed. Mater. Res. A 2015, 103, 981–989. [CrossRef]
[PubMed]
88. Nair, S.; Sasidharan, A.; Divya Rani, V.V.; Menon, D.; Nair, S.; Manzoor, K.; Raina, S. Role of size scale of
ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells. J. Mater. Sci.
Mater. Med. 2009, 20, S235–S241. [CrossRef] [PubMed]
89. Bhowmick, A.; Banerjee, S.L.; Pramanik, N.; Jana, P.; Mitra, T.; Gnanamani, A.; Das, M.; Kundu, P.P.
Organically modified clay supported chitosan/hydroxyapatite-zinc oxide nanocomposites with enhanced
mechanical and biological properties for the application in bone tissue engineering. Int. J. Biol. Macromol.
2018, 106, 11–19. [CrossRef] [PubMed]
90. Gowri, S.; Gandhi, R.R.; Sundrarajan, M. Structural, optical, antibacterial and antifungal properties of
zirconia nanoparticles by biobased protocol. J. Mater. Sci. Mater. Med. 2014, 30, 782–790. [CrossRef]
91. Clarke, I.C.; Green, D.D.; Pezzoti, G.; Donaldson, D. 20 Year Experience of Zirconia Total Hip Replacements.
In Bioceramics and Alternative Bearings in Joint Arthroplasty, 1st ed.; D’Antonio, J.A., Dietrich, M., Eds.;
Steinkopff: Dresden, Germany, 2005; pp. 67–78. ISBN 978-3-7985-1518-5.
92. Oetzel, C.; Clasen, R. Preparation of zirconia dental crowns via electrophoretic deposition. J. Mater. Sci.
Mater. 2006, 41, 8130–8137. [CrossRef]
93. Assal, P.A. The osseointegration of zirconia dental implants. Schweiz Monatsschr. Zahnmed. 2013, 123, 644–654.
[PubMed]
94. Gaihrea, B.; Jayasuriya, A.C. Comparative investigation of porous nano-hydroxyapaptite/chitosan,
nano-zirconia/chitosan and novel nano-calcium zirconate/chitosan composite scaffolds for their potential
applications in bone regeneration. Mater. Sci. Eng. C 2018, 91, 330–339. [CrossRef]
95. Jangra, S.L.; Stalin, K.; Dilbaghi, N.; Kumar, S.; Tawale, J.; Singh, S.P.; Pasricha, R. Antimicrobial activity
of zirconia (ZrO2) nanoparticles and zirconium complexes. J. Nanosci. Nanotechnol. 2012, 12, 7105–7112.
[CrossRef]
Materials 2019, 12, 314 18 of 20
96. Fathima, J.B.; Pugazhendhi, A.; Venis, R. Synthesis and characterization of ZrO2 nanoparticles-antimicrobial
activity and their prospective role in dental care. Microb. Pathog. 2017, 110, 245–251. [CrossRef] [PubMed]
97. Banerjee, K.; Prithviraj, M.; Augustine, N.; Pradeep, S.P.; Thiagarajan, P. Analytical characterization and
antimicrobial activity of nano zirconia particles. J. Chem. Pharm. Sci. 2016, 9, 1186–1190.
98. Dusad, A.; Chakkalakal, D.A.; Namavar, F.; Haider, H.; Hanisch, B.; Duryee, M.J.; Diaz, A.; Rensch, A.;
Zhang, Y.; Hess, R.; et al. Titanium implant with nanostructured zirconia surface promotes maturation of
peri-implant bone in osseointegration. Proc. Inst. Mech. Eng. H 2013, 227, 510–522. [CrossRef] [PubMed]
99. Waldvogel-Abramowski, S.; Waeber, G.; Gassner, C.; Buser, A.; Frey, B.M.; Favrat, B.; Tissot, J.D. Physiology
of iron metabolism. Transfus. Med. Hemother. 2014, 41, 213–221. [CrossRef] [PubMed]
100. Abraham, R.; Walton, J.; Russell, L.; Wolman, R.; Wardley-Smith, B.; Green, J.R.; Mitchell, A.; Reeve, J.
Dietary determinants of post-menopausal bone loss at the lumbar spine: A possible beneficial effect of iron.
Osteoporos. Int. 2006, 17, 1165–1173. [CrossRef] [PubMed]
101. Heo, D.N.; Kung, H.M.; Gi, H.C.; Il, K.K.; Kinam, P.; Sang, C.L. Scale-Up Production of Theranostic
Nanoparticles. In Cancer Theranostics; Chen, X., Wong, S., Eds.; Academic Press: Burlington, MA, USA, 2014;
pp. 457–470. ISBN 978-0-12-407722-5.
102. Wang, Y.X.; Xuan, S.; Port, M.; Idee, J.M. Recent advances in superparamagnetic iron oxide nanoparticles for
cellular imaging and targeted therapy research. Curr. Pharm. Des. 2013, 19, 6575–6593. [CrossRef]
103. Lovati, A.B.; Vianello, E.; Talò, G.; Recordati, C.; Bonizzi, L.; Galliera, E.; Broggini, M.; Moretti, M.
Biodegradable microcarriers as cell delivery vehicle for in vivo transplantation and magnetic resonance
monitoring. J. Biol. Regul. Homeost. Agents 2011, 25, S63–S74.
104. Barzan, E.; Mehrabian, S.; Irian, S. Antimicrobial and Genotoxicity Effects of Zero-valent Iron Nanoparticles.
Jundishapur J. Microbiol. 2014, 7, e10054. [CrossRef]
105. Auffan, M.; Achouak, W.; Rose, J.; Roncato, M.A.; Chanéac, C.; Waite, D.T.; Masion, A.; Woicik, J.C.;
Wiesner, M.R.; Bottero, J.Y. Relation between the redox state of iron-based nanoparticles and their cytotoxicity
toward Escherichia coli. Environ. Sci. Technol. 2008, 42, 6730–6735. [CrossRef]
106. Ismail, R.A.; Sulaiman, G.M.; Abdulrahman, S.A.; Marzoog, T.R. Antibacterial activity of magnetic iron oxide
nanoparticles synthesized by laser ablation in liquid. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 53, 286–297.
[CrossRef]
107. Margabandhu, M.; Sendhilnathan, S.; Maragathavalli, S.; Karthikeyan, V.; Annadurai, B. Synthesis
characterization and antibacterial activity of iron oxide nanoparticles. Glob. J. Bio Sci. Biotechnol. 2015, 4, 335.
108. Soenen, S.J.; De Cuyper, M.; De Smedt, S.C.; Braeckmans, K. Investigating the toxic effects of iron oxide
nanoparticles. Methods Enzymol. 2012, 509, 195–224. [CrossRef] [PubMed]
109. Jarockyte, G.; Daugelaite, E.; Stasys, M.; Statkute, U.; Poderys, V.; Tseng, T.C.; Hsu, S.H.; Karabanovas, V.;
Rotomskis, R. Accumulation and Toxicity of Superparamagnetic Iron Oxide Nanoparticles in Cells and
Experimental Animals. Int. J. Mol. Sci. 2016, 17, 1193. [CrossRef] [PubMed]
110. Yin, G.; Huang, Z.; Deng, M.; Zeng, J.; Gu, J. Preparation and cell response of bio-mineralized Fe3O4
nanoparticles. J. Colloid Interface Sci. 2011, 363, 393–402. [CrossRef] [PubMed]
111. Jia, Y.P.; Ma, B.Y.; Wei, X.W.; Qian, Z.Y. The in vitro and in vivo toxicity of gold nanoparticles. Chin. Chem.
Lett. 2017, 28, 691–702. [CrossRef]
112. Petersen, S.; Barcikowski, S. In Situ Bioconjugation: Single Step Approach to Tailored Nanoparticle-
Bioconjugates by Ultrashort Pulsed Laser Ablation. Adv. Funct. Mater. 2009, 19, 1167–1172. [CrossRef]
113. Schröfel, A.; Kratošová, G.; Šafarˇík, I.; Šafarˇíková, M.; Raška, I.; Shor, L.M. Applications of biosynthesized
metallic nanoparticles—A review. Acta Biomater. 2014, 10, 4023–4042. [CrossRef] [PubMed]
114. Hemeg, H.A. Nanomaterials for alternative antibacterial therapy. Int. J. Nanomed. 2017, 12, 8211–8225.
[CrossRef]
115. Vaseeharan, B.; Ramasamy, P.; Chen, J.C. Antibacterial activity of silver nanoparticles (Ag NPs) synthesized
by tea leaf extracts against pathogenic Vibrio harveyi and its protective efficacy on juvenile Feneropenaeus
indicus. Lett. Appl. Microbiol. 2010, 50, 352–356. [CrossRef]
116. MubarakAli, D.; Thajuddin, N.; Jeganathan, K.; Gunasekaran, M. Plant extract mediated synthesis of silver
and gold nanoparticles and its antibacterial activity against clinically isolated pathogens. Colloids Surf. B
Biointerfaces 2011, 85, 360–365. [CrossRef]
Materials 2019, 12, 314 19 of 20
117. Park, Y. New paradigm shift for the green synthesis of antibacterial silver nanoparticles utilizing plant
extracts. Toxicol. Res. 2014, 30, 169–178. [CrossRef] [PubMed]
118. Zewde, B.; Ambaye, A.; Stubbs, J., III; Dharmara, R. A Review of Stabilized Silver Nanoparticles—Synthesis,
Biological Properties, Characterization, and Potential Areas of Applications. JSM Nanotechnol. Nanomed.
2016, 4, 1043.
119. Pulido, L.; Ghanem, E.; Joshi, A.; Purtill, J.J.; Parvizi, J. Periprosthetic Joint Infection: The incidence, timing,
and predisposing factors. Clin. Orthop. Relat. Res. 2008, 466, 1710–1715. [CrossRef] [PubMed]
120. De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomed. 2008,
3, 133–149. [CrossRef]
121. Hajipour, M.J.; Fromm, K.M.; Ashkarran, A.A.; Jimenez de Aberasturi, D.; de Larramendi, I.R.; Rojo, T.;
Serpooshan, V.; Parak, W.J.; Mahmoudi, M. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012,
30, 499–511. [CrossRef] [PubMed]
122. Dimic´, I.; Cvijovic´-Alagic´, I.; Rakin, M.; Bugarski, B. Analysis of metal ion release from biomedical implants.
Metall. Mater. Eng. 2013, 19, 167–176.
123. Polyzois, I.; Nikolopoulos, D.; Michos, I.; Patsouris, E.; Theocharis, S. Local and systemic toxicity of nanoscale
debris particles in total hip arthroplasty. J. Appl. Toxicol. 2012, 32, 255–269. [CrossRef] [PubMed]
124. Sivolella, S.; Stellini, E.; Brunello, G.; Gardin, C.; Ferroni, L.; Bressan, E.; Zavan, B. Silver nanoparticles in
alveolar bone surgery devices. J. Nanomater. 2012, 2012, 15. [CrossRef]
125. Biopharma Navigator. Available online: https://www.biopharmanavigator.com/bpn/#login (accessed on
6 November 2018).
126. Wallace, D.R. Nanotoxicology and metalloestrogens: Possible involvement in breast cancer. Toxics 2015, 3,
390–413. [CrossRef]
127. Brandt, O.; Mildner, M.; Egger, A.E.; Groessl, M.; Rix, U.; Posch, M.; Keppler, B.K.; Strupp, C.; Mueller, B.;
Stingl, G. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological
side effects than silver sulfadiazine. Nanomedicine 2012, 8, 478–488. [CrossRef]
128. Vik, H.; Andersen, K.J.; Julshamn, K.; Todnem, K. Neuropathy caused by silver absorption from arthroplasty
cement. Lancet 1985, 1, 872. [CrossRef]
129. Sudmann, E.; Vik, H.; Rait, M.; Todnem, K.; Andersen, K.J.; Julsham, K.; Flesland, O.; Rungby, J. Systemic
and local silver accumulation after total hip replacement using silver-impregnated bone cement. Med. Prog.
Technol. 1994, 20, 179–184. [PubMed]
130. Qin, H.; Cao, H.; Zhao, Y.; Zhu, C.; Cheng, T.; Wang, Q.; Peng, X.; Cheng, M.; Wang, J.; Jin, G.; et al.
In vitro and in vivo anti-biofilm effects of silver nanoparticles immobilized on titanium. Biomaterials 2014,
35, 9114–9125. [CrossRef] [PubMed]
131. James, L.R.; Xu, Z.Q.; Sluyter, R.; Hawksworth, E.L.; Kelso, C.; Lai, B.; Paterson, D.J.; de Jonge, M.D.;
Dixon, N.E.; Beck, J.L.; et al. An investigation into the interactions of gold nanoparticles and anti-arthritic
drugs with macrophages, and their reactivity towards thioredoxin reductase. J. Inorg. Biochem. 2015, 142,
28–38. [CrossRef] [PubMed]
132. Bhattacharya, P.; Mukherjee, P. Biological properties of naked metal nanoparticles. Adv. Drug Deliv. Rev.
2008, 60, 1289–1306. [CrossRef] [PubMed]
133. Connor, E.E.; Mwamuka, J.; Gole, A.; Murphy, C.J.; Wyatt, M.D. Gold nanoparticles are taken up by human
cells but do not cause acute cytotoxicity. Small 2005, 1, 325–327. [CrossRef] [PubMed]
134. Bobo, D.; Robinson, K.J.; Islam, J.; Thurecht, K.J.; Corrie, S.R. Nanoparticle-Based Medicines: A Review of
FDA-Approved Materials and Clinical Trials to Date. Pharm. Res. 2016, 33, 2373–2387. [CrossRef]
135. Villiers, C.L.; Freitas, H.; Couderc, R.; Villiers, M.B.; Marche, P.N. Analysis of the toxicity of gold nano
particles on the immune system: Effect on dendritic cell functions. J. Nanopart. Res. 2010, 12, 55–60.
[CrossRef] [PubMed]
136. Osredkar, J.; Sustar, N. Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance. J. Clin.
Toxicol. 2011, 001. [CrossRef]
137. Chen, P.; Bornhorst, J.; Diana Neely, M.; Avila, D.S. Mechanisms and Disease Pathogenesis Underlying
Metal-Induced Oxidative Stress. Oxid. Med. Cell. Longev. 2018, 2018, 7612172. [CrossRef]
Materials 2019, 12, 314 20 of 20
138. Buracco, S.; Peracino, B.; Andreini, C.; Bracco, E.; Bozzaro, S. Differential Effects of Iron, Zinc, and Copper
on Dictyostelium discoideum Cell Growth and Resistance to Legionella pneumophila. Front. Cell. Infect.
Microbiol. 2018, 7, 536. [CrossRef] [PubMed]
139. Lee, S.R. Critical Role of Zinc as Either an Antioxidant or a Prooxidant in Cellular Systems. Oxid. Med. Cell.
Longev. 2018, 2018, 9156285. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
